L03AX17B24 Product Details

We are currently one of the very few manufacturers of L03AX17B24 SIPULEUCEL-T2 B-VARIANT 2024

We adhere to the highest international standards of manufacturing and safety.

We believe vaccines should be available to everyone, everywhere.

Transparency and integrity guide every decision we make

CETRON’s Cancer vaccine portfolio focuses on high-impact diseases affecting populations across Latin America and beyond.